Icosagen

Icosagen is a unique European CRDMO, being successfully in the biotech and pharma industry for more than 25 years as an independent family-owned company. As such, we combine pre-clinical CRO and clinical CDMO development expertise at one single site for therapeutic antibodies, ADCs, and other complex recombinant protein drug candidates. This includes everything from small-scale transient productions to stable high producing cell lines, to manufacture clinical GMP materials in our modern 200/1000L GMP facility. We help biotech and pharma companies accelerate complex protein drug development by uniting pre-clinical CRO and clinical CDMO services under one roof - eliminating costly tech transfers, reducing risk, and preserving critical molecule know-how.